Fidelity Investments’s Cerenome, Inc. Common Stock CNSY Stock Holding History

Fidelity Investments’s Portfolio CNSY Stock Details CNSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5	Closed	-$580	–	5555
2023 Q1	$580	Buy	+5	New	+$673	﹤0.01%	4782
2020 Q4	–	Hold	0	–	–	–	4197
2020 Q3	–	Hold	0	–	–	–	3929
2020 Q2	–	Hold	0	–	–	–	4054

Other funds holding CNSY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Fidelity Investments's CNSY Position: Q2 2023 in Review

Fidelity Investments sold out of Cerenome, Inc. Common Stock (CNSY) in Q2 2023, closing a stake of 5 shares — an estimated $580 sold.

Fidelity Investments first reported a position in CNSY in Q1 2023 and held it in 1 quarter. The position peaked at $580 in Q1 2023. 6 funds tracked by Wall St. Rank hold CNSY as of Q2 2023.

Fidelity Investments reported no remaining Cerenome, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Fidelity Investments sold 5 Cerenome, Inc. Common Stock shares in Q2 2023, an estimated $580.
Fidelity Investments first reported a position in Cerenome, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Fidelity Investments's Cerenome, Inc. Common Stock position peaked at $580 in Q1 2023.
6 funds tracked by Wall St. Rank held Cerenome, Inc. Common Stock as of Q2 2023.

Based on Fidelity Investments's 13F filing for Q2 2023, filed 11 Aug 2023.